These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 4129483)
1. Activation of the complement system. Cooper NR Contemp Top Mol Immunol; 1973; 2():155-83. PubMed ID: 4129483 [No Abstract] [Full Text] [Related]
2. Immunobiology of complement. Burkholder PM; Littleton CE Pathobiol Annu; 1971; 1():215-39. PubMed ID: 4129958 [No Abstract] [Full Text] [Related]
3. [Genetically controlled disorders of the human complement system]. Brackertz D Schweiz Med Wochenschr; 1974 Jun; 104(22):777-84. PubMed ID: 4135190 [No Abstract] [Full Text] [Related]
4. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity. Glovsky MM; Cory M; Alenty A Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824 [TBL] [Abstract][Full Text] [Related]
5. Genetic aspects of diseases of complement: an explosion. Polley MJ; Bearn AG Am J Med; 1975 Jan; 58(1):105-11. PubMed ID: 46701 [No Abstract] [Full Text] [Related]
6. Enzyme activation and the mechanism of neutrophil chemotaxis. Becker EL Antibiot Chemother (1971); 1974; 19():409-20. PubMed ID: 4142851 [No Abstract] [Full Text] [Related]
7. [Clinical importance of the complement system]. Spath P; Huber H Wien Klin Wochenschr; 1973 Jun; 85(25):445-50. PubMed ID: 4123223 [No Abstract] [Full Text] [Related]
9. C1-bypass complement-activation pathway in patients with chronic urticaria and angio-oedema. Ballow M; Ward GW; Gershwin ME; Day NK Lancet; 1975 Aug; 2(7928):248-50. PubMed ID: 49798 [TBL] [Abstract][Full Text] [Related]
11. The role of late complement components and the alternate complement pathway in experimental cryptococcosis. Diamond RD; May JE; Kane M; Frank MM; Bennett JE Proc Soc Exp Biol Med; 1973 Oct; 144(1):312-5. PubMed ID: 4129497 [No Abstract] [Full Text] [Related]
14. Disorders of the complement and properdin systems. Alper CA; Rosen FS Ciba Found Symp; 1972; 9():283-96. PubMed ID: 4121647 [No Abstract] [Full Text] [Related]
15. The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure. Lachmann PJ; Kay AB; Thompson RA Immunology; 1970 Dec; 19(6):895-9. PubMed ID: 5487541 [TBL] [Abstract][Full Text] [Related]
16. A molecular approach to the complement system. Fothergill JE; Anderson WH Curr Top Cell Regul; 1978; 13():259-311. PubMed ID: 352622 [No Abstract] [Full Text] [Related]
20. Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG. MacLennan IC; Connell GE; Gotch FM Immunology; 1974 Feb; 26(2):303-10. PubMed ID: 4277464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]